Defiance Daily Target 2X Long NVO ETF (NVOX)

NYSEARCA: NVOX · Real-Time Price · USD
10.27
-0.11 (-1.06%)
Feb 27, 2026, 4:00 PM EST - Market closed
Assets$37.08M
Expense Ratio1.30%
PE Ration/a
Shares Out3.61M
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
Volume1,333,547
Open10.35
Previous Close10.38
Day's Range10.21 - 10.50
52-Week Low10.21
52-Week High100.40
Betan/a
Holdings12
Inception DateDec 2, 2024

About NVOX

Fund Home Page

The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.

Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NYSEARCA
Ticker Symbol NVOX
ETF Provider Defiance

Top 10 Holdings

312.48% of assets
NameSymbolWeight
NOVO-NORDISK SWAP MSn/a59.76%
US DOLLARSn/a49.71%
OTHER ASSETS AND LIABILITIESn/a44.64%
NOVO-NORDISK SWAP NBC-Ln/a32.64%
NOVO-NORDISK SWAP CLEARSTREETn/a22.66%
NOVO-NORDISK INC SWAP CANTORn/a22.14%
NOVO-NORDISK SWAP MAREXn/a22.10%
NOVO-NORDISK SWAP BMO-Ln/a22.10%
NOVO-NORDISK A/S-SPONS ADR NOMURAn/a21.59%
United States Treasury Bills 0%B.0 03.19.2615.15%
View More Holdings

Performance

NVOX had a total return of -89.38% in the past year, including dividends. Since the fund's inception, the average annual return has been -89.52%.

News

Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo Nordisk

MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss marke...

Other symbols: NVO
1 year ago - GlobeNewsWire